Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Apr 20;111(1):249–259. doi: 10.1016/j.ijrobp.2021.03.058

Fig. 4.

Fig. 4.

Specific lung transcriptomic analysis (RNA sequencing) in survivors and nonsurvivors. (A) Unsupervised principal component analysis of primate lung RNA sequencing data shows clear clustering into controls, nonsurvivors, and survivors (blue = controls, red = nonsurvivors, and yellow = survivors). (B) Venn diagram of differentially expressed transcripts by group comparisons. Values indicate the number of transcripts with significant differential expression (P < .05) across that contrast: nonsurvivors versus controls (2644); survivors versus controls (680); nonsurvivor-specific (2202), survivor-specific (238), and shared transcripts (422); along with canonical pathways elicited by nonsurvivor- and survivor-specific differentially expressed genes (DEGs) using ingenuity pathway analysis. (C) Upstream regulators (using Ingenuity Pathway Analysis) of nonsurvivor- and survivor-specific DEGs are illustrated by the Venn diagram. (D, E) Hierarchical clustering combined with a heat map of nonsurvivor- and survivor-specific DEGs shows clear differentiation between groups, listed with their top 5 upregulated and downregulated transcripts. Significant differentially expressed genes (DEGs) were conservatively defined as log2 fold change ratios ≥±1 and P values <.05 after adjustment for false discovery.